Track market-moving stories before they get noisy

Pablo’s Revenge, Dante’z Inferno, and Frost’d Flakes launched under Tweed brand

Up to five additional strains expected to follow in June 2026

Company targeting rapid growth in Germany’s medical cannabis market

SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. (“MTL”), a wholly-owned subsidiary of the Company. The dual milestone represents the Company’s first international product release following its recent acquisition of MTL.

The Tweed brand relaunch – now powered by MTL’s premium genetics – signals the Company’s commitment to leveraging the full equity of its legacy brand in key international markets and comes as Germany’s medical cannabis market continues to expand rapidly, approaching $1 billion in annual value in 20251. The MTL acquisition has enhanced Canopy Growth’s capacity to meet rising demand in key international markets, including Germany, while reintroducing a brand that physicians and patients have come to trust.

"Germany is one of the fastest-growing medical cannabis markets globally, and demand continues to scale rapidly. The relaunch of our Tweed brand is a meaningful moment for us, reflecting both the strength of what we have built, and our commitment to delivering consistent, high-quality cannabis that physicians can prescribe with confidence and patients can rely on as part of their care. We believe the European Union represents a tremendous opportunity for Canopy, and Germany is just the beginning,” said Luc Mongeau, Chief Executive Officer, Canopy Growth.

The initial launch includes three cultivars – Pablo’s Revenge, Dante’z Inferno, and Frost’d Flakes – selected for their quality and consistency. Up to five MTL-derived strains are expected to be introduced in June 2026, with further portfolio expansion planned throughout the year.

The Company also announced today that it has been granted a management cease trade order effective as of May 28, 2026, by its principal regulator, the Ontario Securities Commission under National Policy 12-203 – Management Cease Trade Orders. This follows the Company’s announcement on May 15, 2026 regarding certain non-cash technical errors in the Company’s accounting relating to certain share-settled warrants of the Company with exercise prices denominated in U.S. dollars, first issued during the fiscal year ended March 31, 2024. The Company intends to refile the relevant financial statements (the “Refiling”) in its Annual Report on Form 10-K for the fiscal year ended March 31, 2026, which is expected to be filed with Canadian securities regulators and with the United States Securities and Exchange Commission (the “SEC”) on June 15, 2026 (the “Comprehensive Form 10-K”).

About Canopy Growth

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives. Its portfolio of owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, Deelish, Claybourne, MTL Cannabis, Low Key by MTL and R’belle, as well as category defining Storz & Bickel, delivers innovative products to consumers across Canada and beyond.

Canopy Growth is Canada’s leading provider of medical cannabis services through Canada House Clinics and serves patients online via Abba Medix. The Company also holds unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.

Committed to quality, responsible use, and community, Canopy Growth is shaping a future where cannabis is embraced for its potential to enhance well-being.

For more information visit www.canopygrowth.com

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements and uncertainties include statements with respect to the occurrence, timing and expectations relating to further portfolio expansion in European markets including an additional five MTL-derived strains expected to be introduced in 2026; the outstanding work and the planned filing of the Refiling; the expected timing of the filing of the Comprehensive Form 10-K; disclosure of further updates and bi-weekly status reports with respect to the MCTO; the timing, duration and impacts with respect to the MCTO; and expectations for other economic, business, and/or competitive factors.

Risks, uncertainties and other factors involved with forward-looking information or statements could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including delays in completing the Refiling and the Comprehensive Form 10-K; risks relating to the dilutive impact of the transactions and future resales of Common Shares in the public market, which may negatively affect the stock price of Common Shares; negative operating cash flow; uncertainty of additional financing; use of proceeds; volatility in the price of the Common Shares; risks relating to the overall macroeconomic environment, which may impact customer spending, costs and margins, including tariffs (and related retaliatory measures), the levels of inflation, and interest rates; expectations regarding future investment, growth and expansion of operations; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; legal and regulatory risks inherent in the cannabis industry, including the global regulatory landscape and enforcement related to cannabis; additional dilution; political risks and risks relating to regulatory change, including with respect to reimbursement rates in the medical cannabis market; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the cannabis industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR+ at www.sedarplus.ca and with the SEC through EDGAR at www.sec.gov/edgar, including under the heading “Risk Factors” in the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2025 and its subsequently filed quarterly reports on Form 10-Q.

In respect of the forward-looking statements and information, the Company has provided such statements and information in reliance on certain assumptions that they believe are reasonable at this time. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information or statements and no assurance can be given that such events will occur in the disclosed time frames or at all. Should one or more of the foregoing risks or uncertainties materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information or forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

In the latest close session, Canopy Growth Corporation (CGC - Free Report) was down 1.85% at $1.06. The stock fell short of the S&P 500, which registered a gain of 0.13% for the day. Elsewhere, the Dow gained 0.45%, while the tech-heavy Nasdaq added 0.03%.

The company's stock has dropped by 1.82% in the past month, falling short of the Medical sector's gain of 1.01% and the S&P 500's gain of 5.25%.

The upcoming earnings release of Canopy Growth Corporation will be of great interest to investors. The company's earnings report is expected on June 15, 2026. The company is predicted to post an EPS of -$0.06, indicating a 93.62% growth compared to the equivalent quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $53.26 million, up 17.56% from the prior-year quarter.

For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.36 per share and a revenue of $210.58 million, representing changes of +87.92% and +8.94%, respectively, from the prior year.

Investors should also note any recent changes to analyst estimates for Canopy Growth Corporation. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Canopy Growth Corporation presently features a Zacks Rank of #3 (Hold).

The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 153, this industry ranks in the bottom 38% of all industries, numbering over 250.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Canopy Growth Corporation (CGC - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this company have returned -9.6% over the past month versus the Zacks S&P 500 composite's +4.6% change. The Zacks Medical - Products industry, to which Canopy Growth belongs, has lost 4.3% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Canopy Growth is expected to post a loss of $0.06 per share, indicating a change of +93.6% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

For the current fiscal year, the consensus earnings estimate of -$0.36 points to a change of +87.9% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $0.11 indicates a change of +69.4% from what Canopy Growth is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Canopy Growth is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Canopy Growth, the consensus sales estimate of $53.26 million for the current quarter points to a year-over-year change of +17.6%. The $210.58 million and $278.96 million estimates for the current and next fiscal years indicate changes of +8.9% and +32.5%, respectively.

Last Reported Results and Surprise HistoryCanopy Growth reported revenues of $53.47 million in the last reported quarter, representing a year-over-year change of +0.1%. EPS of -$0.1 for the same period compares with -$0.76 a year ago.

Compared to the Zacks Consensus Estimate of $50.59 million, the reported revenues represent a surprise of +5.7%. The EPS surprise was -233.33%.

Over the last four quarters, Canopy Growth surpassed consensus EPS estimates two times. The company topped consensus revenue estimates two times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Canopy Growth is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Canopy Growth. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that Claybourne’s Frosted Flyers Variety Pack has been awarded Best Infused Pre-Roll at the 2026 Grow Up Awards, presented during the annual Grow Up Conference & Expo in Toronto.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608930080/en/

Frosted Flyers Variety Pack

Building on that recognition, the Company also announced the expansion of Claybourne’s Frosted Flyers infused pre-roll lineup in Canada, with three new 8-pack variety formats and the brand’s first bundle pack.

“Winning Best Infused Pre-Roll at Grow Up is a clear signal that consumers and the industry are responding to what Claybourne is building in Canada,” said Luc Mongeau, Chief Executive Officer, Canopy Growth. “Frosted Flyers was designed to bring more flavour and energy to the infused pre-roll category, and this recognition tells us we’re delivering on that. Today’s expansion extends our market share momentum, giving consumers more ways to discover the brand and more reasons to reach for Claybourne this summer.”

The expanded Frosted Flyers infused pre-roll lineup includes:

Frosted Flyers Podium Pack | 8x0.35g | Eight flavours, eight pre-rolls, one variety pack Frosted Flyers Fast Pack | 8x0.35g | Four sativa flavours, eight pre-rolls, two of each flavour Frosted Flyers Drag Pack | 8x0.35g | Four indica flavours, eight pre-rolls, two of each flavour Frosted Flyers Variety Bundle Pack | 2x5x0.5g | Five flavours, 10 pre-rolls, one cost-effective bundle pack With the addition of the Podium Pack, Fast Pack, Drag Pack, and Variety Bundle Pack, Claybourne is extending its position in multi-pack formats while meeting growing consumer demand for variety and convenience – expanding at a key seasonal moment.

“‘Built on Variety’ started as a product idea and has since evolved into a core part of our product identity,” said Jonathan Griffith, Co-Founder and VP of Marketing at Claybourne Co. “Consumers want options, and they want products that fit different occasions. These new 8x0.35g Podium, Fast and Drag packs build on that momentum with quicker sessions, more flavour rotation and curated experiences designed around how people actually consume.”

Availability

The new Frosted Flyers variety packs are now rolling out at select retail stores across Canada, with all formats available this summer.

About Canopy Growth

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives. Its portfolio of owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, Deelish, Claybourne, MTL Cannabis, Low Key by MTL and R’belle, as well as category defining Storz & Bickel, delivers innovative products to consumers across Canada and beyond.

Canopy Growth is one of Canada’s leading providers of medical cannabis services through Canada House Clinics and serves patients online via Abba Medix. The Company also holds an unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.

Committed to quality, responsible use, and community, Canopy Growth is shaping a future where cannabis is embraced for its potential to enhance well-being.

For more information visit www.canopygrowth.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260608930080/en/

The cannabis industry has been a disappointment. Although Wall Street had high hopes for marijuana stocks toward the end of the last decade, as legal and regulatory progress in the market made pot growers more attractive, almost every one of them has significantly underperformed broader equities in recent years. Tilray Brands (TLRY 2.73%), a leader in the industry, has been no exception: The company's shares have declined by more than 90% over the past five years. However, some investors hope that recent developments in the U.S. cannabis market could be a turning point for Tilray. Is now a good time to bet on the stock?

Image source: The Motley Fool.

A gift from the government Following an executive order signed by President Trump, products approved by the U.S. Food and Drug Administration that contain marijuana -- as well as medical cannabis products that are legal in certain states -- have been moved from Schedule I to Schedule III. Here's what that means. Under federal law, Schedule I substances are deemed the most addictive while having no recognized medical benefits. Products in the Schedule III category are considered less prone to abuse. This change will make it easier to research potential health-related benefits of marijuana, something that could move the needle for pot growers that operate in the U.S. Tilray is ready to take on this opportunity through its footprints in the U.S. market, where it offers a variety of CBD and hemp-based products, as well as a craft-brewing business.

We have seen this movie before It's worth noting that the recent rescheduling decision does not include recreational marijuana. However, there is a hearing on the books for next month to discuss whether other forms of cannabis should also be rescheduled. Even assuming the best-case scenario for Tilray, though, it is less than clear that this will be the major turning point many investors hope for. Rescheduling cannabis wouldn't make the substance legal at the federal level. So, significant barriers would remain.

Today's Change

(

-2.73

%) $

-0.14

Current Price

$

4.98

For instance, it would still be illegal to ship the substance across state lines. This restriction forces many cannabis companies to own and operate facilities to cultivate and process cannabis -- as well as to make various products derived from the substance -- in every state where they do business, instead of relying on one or a few such sites spread out in several states that ship products to every other one. This is an incredibly inefficient way to do business that pot growers are forced into, leading to significantly higher operating expenses than they would otherwise incur.

That's one of the reasons most cannabis companies in the U.S. are unprofitable. True, rescheduling will help medical cannabis companies in the country by allowing them to deduct normal business expenses (companies selling Schedule I or Schedule II drugs aren't allowed to do that), thereby lowering operating costs. But there are other problems. Just like it dealt with significant competition in Canada once recreational uses of cannabis were legalized in the country in 2018, Tilray might encounter the same issue here.

Even with the company's large portfolio of products and brands, it isn't clear that it has developed a competitive advantage that would allow it to emerge as one of the winners. And that would be the case even if federal legalization happens in the U.S. That might certainly open massive opportunities, but it would also attract far larger corporations with the financial means, brand recognition, and expertise in navigating industries with tough regulatory landscapes.

In fairness to Tilray, it has significantly diversified its lineup in recent years. It is now the fourth-largest craft brewer in the U.S. thanks to a series of acquisitions. That said, the company continues to generate inconsistent revenue growth. It also remains unprofitable.

TLRY Revenue (Annual) data by YCharts

Given Tilray's track record, its poor financial results, and the industry's uncertainty, it's hard to make a solid case that the company's long-term outlook is attractive. Investors shouldn't bother with this stock, even though it is trading just slightly above penny-stock territory.

Tilray Brands NASDAQ:TLRY stock price has plummeted this year, and is now hovering at its lowest level since July last year. It has plunged by 76% from its highest point last year, meaning that a $10,000 investment at its peak would be about $2,100 today. 

Tilray Brands and other cannabis companies have come under intense pressure. While the cannabis industry is growing in key countries, the reality is that it has not become the vibrant sector that people were expecting after the famous Supreme Court ruling. 

Recent studies estimate that the US market size for cannabis stands at over $30 billion, with its compounded annual growth rate (CAGR) being 4.5%. In the past, estimates were that it would have double digit growth rates over time.

Tilray shares jumped to $9.30 in April after the US made efforts to reclassify cannabis into a less dangerous drug. This happened after the industry spent millions of dollars lobbying and financing Trump’s campaign.

The reclassification would benefit Tilray Brands as it has expressed a desire to enter the market. Still, the proces will take time, including a lawsuit brought by prohibitionist organization and drug-testing groups. These lawsuits are the ones that derailed Joe Biden’s reclassification efforts.

Meanwhile, the company’s entry into the beverage industry is not going on as planned. A look at its financial reports shows that its revenue and margins have remained under pressure in the past few months. 

The most recent results showed that its revenue dropped to $42.6 million in the last quarter from $56 million in the same period last year. Its gross margin also dropped to 32% from the previous 36%. It was the worst-performing division in its business in terms of revenue growth. 

The company has also continued to lose money in the past few years. Its loss improved to $25.2 million in the quarter compared to a $793 million in the same period a year earlier. Still, it will take longer for the company to achieve stable profits.

These fears explain why investors have continued to short the stock. Data shows that its short interest has jumped to 16.4%, higher than other companies in the industry. This rising short interest is putting more pressure on its business.

Analysts expect that Tilray’s revenue will continue to grow in the near term. The average estimate is that its annual revenue will jump by 7.6% this year to $884 million, followed by $1.1 billion next year.

TLRY stock chart | Source: TradingView

The daily chart shows that the TLRY share price has crashed in the past few months. After peaking at $9.30 in April, it has plunged to $5.45 today. It has moved below the important support level at $5.96, its lowest level in April, confirming the bearish outlook.

The stock has remained below the 50-day and 100-day Exponential Moving Averages (EMA). Remaining below these averages is a sign that bears have prevailed today.

Tilray remains below the Ichimoku Cloud and the Supertrend indicator. Therefore, the most likely scenario is where it continues falling, potentially to the psychological level at $5. A move below that level will point to more downside towards $4.5.

However, it is worth noting that Tilray and other cannabis companies are often highly volatile when major news come out. As such, there is also a possibility that it will have a short squeeze.

Top Canadian Cannabis Stocks to Watch Before June 2026 The Canadian cannabis sector continues showing signs of long-term potential heading into June 2026. Several companies are expanding globally while improving operational efficiency. In addition, many cannabis investors are watching for future developments in the United States’ reform. Those possible reforms could create new growth opportunities across the industry. However, volatility remains high in cannabis stocks. Because of this, traders should continue using technical analysis and proper risk management strategies. Strong balance sheets and improving revenue trends are becoming increasingly important for investors. Furthermore, companies with diversified operations may perform better during uncertain market conditions. Three Canadian cannabis companies continue attracting investor attention this month. These companies include TLRY, CGC, and VFF.

[Read More] Top Multi-State Marijuana Penny Stocks to Watch Right Now

3 Canadian Marijuana Stocks Investors Are Watching Heading Into June 2026 Tilray Brands Inc. (NASDAQ: TLRY) Canopy Growth Corporation (NASDAQ: CGC) Village Farms International Inc. (NASDAQ: VFF) Tilray Brands Inc. (TLRY) Tilray Brands remains one of the most recognized cannabis companies in Canada. The company operates across cannabis, beverage alcohol, and wellness markets. Additionally, Tilray maintains a large international presence throughout Europe and North America. Its strongest exposure in the United States comes through craft beer and beverage operations. Meanwhile, the company continues expanding medical cannabis distribution throughout Europe. Tilray does not currently operate U.S. THC dispensaries because federal legalization has not occurred. However, the company maintains strategic positioning for future American cannabis opportunities. Tilray’s Canadian operations include several cultivation and processing facilities across the country.

The company also owns multiple cannabis brands targeting different consumer categories. Furthermore, Tilray continues focusing on premium products and derivative cannabis items. Investors continue watching the company because of its international diversification strategy. Its broad operational structure provides exposure beyond traditional cannabis sales. In addition, Tilray continues to pursue partnerships and acquisitions to strengthen its market share. Many investors believe the company could benefit significantly from future federal reform in the United States. As a result, TLRY remains one of the most actively traded cannabis stocks entering June 2026.

Latest Financials Tilray recently reported quarterly financial results showing continued revenue diversification. Beverage alcohol sales remained an important contributor to the company’s overall performance. Meanwhile, cannabis revenue was under pressure from price competition across Canada. However, international medical cannabis sales continued showing gradual improvement. Gross margins also improved slightly compared to previous quarters. Additionally, management continued emphasizing cost reductions and operational efficiency initiatives. Tilray reported ongoing efforts to lower production expenses across several facilities. Cash preservation remains another important company objective during current market conditions.

Furthermore, management discussed future growth opportunities in Germany and other European markets. Tilray also continues to reduce debt while strengthening its financial flexibility. Although profitability challenges remain, investors continue to monitor operational progress carefully. Analysts remain focused on whether revenue growth can outpace industry pricing pressure. Still, Tilray’s diversified business model separates it from many cannabis competitors. The company’s beverage operations also provide additional revenue stability during cannabis market weakness. Consequently, many investors continue viewing TLRY as a long-term cannabis industry watchlist candidate.

[Read More] Cannabis REITs Gaining Momentum in 2026: 3 Stocks to Watch

Canopy Growth Corporation (CGC) Canopy Growth Corporation remains another major Canadian cannabis company that investors continue monitoring closely. The company operates recreational and medical cannabis businesses throughout Canada and international markets. Additionally, Canopy maintains strategic exposure to future United States cannabis opportunities. Its largest U.S. positioning comes through cannabis-related investment structures and partnerships. However, federal restrictions still prevent direct THC dispensary operations within the United States. Canopy currently does not operate American cannabis dispensaries. Nevertheless, investors continue to watch the company’s U.S. expansion potential closely.

The company owns several recognized cannabis brands across multiple product categories. These include dried flower, beverages, edibles, and vape products. Furthermore, Canopy continues to emphasize premium cannabis products and the development of the medical market. The company has also focused heavily on restructuring efforts during recent years. Management continues working to streamline operations and improve overall efficiency. In addition, Canopy remains one of the sector’s most widely recognized cannabis brands globally. Investors often view the company as a high-risk, high-reward cannabis opportunity. Strong market reactions frequently follow company updates and restructuring announcements. Therefore, CGC remains one of the most actively watched Canadian cannabis stocks before June 2026.

Latest Financials Canopy recently reported financial results reflecting ongoing restructuring progress and expense reductions. Revenue remained under pressure due to competitive conditions in the Canadian cannabis industry. However, management reported improvements in operational efficiency and cost controls. The company also reduced losses compared to prior reporting periods. Additionally, Canopy continued to focus on premium product categories with higher margins. International medical cannabis operations also provided some positive revenue contributions. Furthermore, management emphasized maintaining liquidity and strengthening the balance sheet.

Cost-cutting measures remained a central part of the company’s turnaround strategy. Investors also continue monitoring Canopy’s path toward sustainable profitability. Although challenges remain, management believes restructuring efforts are creating long-term stability. Canopy also continues evaluating strategic opportunities tied to future U.S. legalization developments. Analysts remain divided regarding the company’s long-term outlook. Nevertheless, many traders continue watching the stock because of its volatility and news sensitivity. Strong price swings often occur following cannabis reform headlines or earnings announcements. Consequently, CGC remains an important stock for cannabis investors to monitor closely before June 2026.

[Read More] 3 Marijuana Stocks For Better Investing In 2026

Village Farms International Inc. (VFF) Village Farms International operates a diversified agricultural and cannabis business model. The company originally built its reputation through greenhouse vegetable production. Later, Village Farms expanded aggressively into the cannabis industry. Today, the company operates cannabis cultivation facilities throughout Canada. Additionally, Village Farms owns the Pure Sunfarms cannabis brand. Pure Sunfarms remains one of Canada’s leading cannabis producers by volume. The company also maintains exposure to potential future opportunities in the United States cannabis market.

However, Village Farms currently does not operate U.S. THC dispensaries because of federal restrictions. Its strongest American presence comes through agricultural operations and CBD-related business activities. Furthermore, Village Farms continues to emphasize efficient, low-cost cannabis cultivation. This strategy has helped the company compete within Canada’s highly competitive cannabis market. Investors often view Village Farms as one of the sector’s more disciplined operators. Management also continues focusing on profitability and operational consistency. In addition, the company benefits from decades of expertise in large-scale greenhouse cultivation. As a result, VFF remains a closely watched cannabis stock entering June 2026.

Latest Financials Village Farms recently reported quarterly financial results showing continued operational improvement. Cannabis revenue remained supported by strong demand for Pure Sunfarms products across Canada. Additionally, management highlighted efforts to improve margins within the cannabis division. The company also continued emphasizing disciplined expense management and production efficiency. Gross profit improved compared to several prior reporting periods. Furthermore, Village Farms maintained a stronger balance sheet than many cannabis competitors. Management also discussed future expansion opportunities within international cannabis markets.

The company continues pursuing growth opportunities while avoiding excessive operational spending. Investors continue monitoring whether profitability trends can remain sustainable throughout 2026. Meanwhile, Village Farms benefits from diversified agricultural operations outside cannabis markets. This diversification may help reduce overall business volatility during difficult industry conditions. Analysts also continue monitoring the company’s ability to gain additional market share in Canada. Furthermore, many investors appreciate Village Farms’ focus on efficiency and disciplined execution. Although the risks in the cannabis sector remain elevated, VFF continues to attract investor attention. Consequently, the stock remains an important Canadian cannabis company to watch before June 2026.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | [email protected]

ATLANTA, June 03, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today unveiled an Atlanta-wide soccer celebration program for summer 2026, transforming the city into a fan destination through stadium activations, downtown experiences, exclusive collaborations, and high-energy watch parties at its iconic Atlanta Taproom.

As Atlanta prepares to welcome hundreds of thousands of visitors for one of the world’s premier international sporting events, including eight matches and a semifinal, SweetWater is bringing together local pride, craft beer culture, and the passion of the global game through a citywide platform designed to connect traveling supporters and hometown fans alike.

As the Official Craft Beer Partner of Atlanta United and Atlanta’s original hometown craft brewery, SweetWater has long been part of the city’s soccer culture. This summer, the brand is expanding that connection through a comprehensive celebration spanning Mercedes-Benz Stadium, downtown fan destinations, local partnerships, and Taproom watch parties designed to showcase the best of Atlanta to supporters from around the globe.

From the heart of downtown to Mercedes-Benz Stadium and SweetWater’s flagship brewery, the brand will activate across Atlanta all summer long with immersive fan experiences, limited-edition merchandise, special beer releases, giveaways, and match-day celebrations that capture the energy of the city and the excitement surrounding the global tournament.

Evan Woolard, Senior Brand Manager for SweetWater Brewing, said, “This summer, Atlanta becomes the center of the soccer world, and SweetWater is proud to help welcome fans from across the globe. As Atlanta’s hometown brewery and the Official Craft Beer Partner of Atlanta United, we’re creating experiences that bring fans together wherever they choose to celebrate the game - from Mercedes-Benz Stadium and downtown fan zones to our Taproom. This is more than a summer promotion; it’s a citywide celebration of sport, community, and the culture that makes Atlanta unique.”

Highlights of SweetWater’s Atlanta Soccer Celebration Program include:

Official Atlanta United watch parties at the SweetWater Taproom on June 17 and July 15, featuring exclusive fan experiences and the opportunity to win a pair of 2027 Atlanta United season tickets.
SweetWater activations at Mercedes-Benz Stadium throughout the summer, bringing Atlanta’s hometown craft beer directly to visiting supporters and local fans through branded experiences, product visibility, and fan engagement opportunities.
Stadium district activations featuring American Lager, Daytrip IPA, and other SweetWater favorites through select can and draft placements, sampling opportunities, and fan-focused experiences, including the brand-new COSM and the South Downtown (SoDo) Open Container Area.
Downtown Atlanta fan activations at high-traffic venues designed to engage visitors and showcase SweetWater’s hometown roots.
Limited-edition collaboration beers and merchandise with Atlantucky Brewing and the legendary hip hop group, Nappy Roots and STATs Brewing in Downtown Atlanta, celebrating Atlanta’s role on the global soccer stage.
SweetWater Taproom watch parties throughout June and July, transforming the brewery into Atlanta’s soccer headquarters with match viewings, special promotions, merchandise, giveaways, and fan programming. SweetWater Brewing is proud to be the Official Beer Partner of the Atlanta Chapter of the American Outlaws U.S. Soccer supporters group.
Fan-first experiences featuring giveaways, branded merchandise, enter-to-win opportunities, custom cups, surprise appearances, and interactive activations throughout the city. Anchoring the campaign is SweetWater’s “Official Beer of the World (Best Enjoyed in America)” creative platform, a playful concept celebrating the global spirit of the game through the lens of Atlanta’s hometown brewery.

Whether fans are arriving from around the world or cheering from their favorite neighborhood bar, SweetWater is bringing Atlanta together with great beer, unforgettable experiences, and a summer-long celebration worthy of the global spotlight. As Atlanta welcomes the world, SweetWater is proud to represent the city it has called home for more than 25 years, bringing together soccer, community, and craft beer through experiences that celebrate the passion of the game and the spirit of Atlanta.

For more information on SweetWater’s summer programming and upcoming events, visit SweetWater’s Atlanta Taproom, 195 Ottley Drive, Atlanta, GA, or follow SweetWater Brewing @sweetwaterbrew on Instagram or Facebook.

About SweetWater Brewing

SweetWater Brewing Company, the largest craft brewer in the southeast, is an award-winning brewery known for its stash of heady brews including the original 420 Extra Pale Ale and loads of IPAs. Sweetwater’s craft beers and ready-to-drink cocktails are available coast to coast and in more states than ever before. Inspired by the outdoors, SweetWater is a passionate advocate for healthy waterways and conservation initiatives. Through its annual Save Our Water campaign, SweetWater continues to raise funds to support nonprofit organizations fighting for clean water and habitat conservation, including the Waterkeeper Alliance, Bonefish & Tarpon Trust, and Trout Unlimited. SweetWater Brewery is a subsidiary of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life. For further information about SweetWater Brewing Company, please visit www.sweetwaterbrew.com and follow @SweetWaterBrew.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For further information, please contact

Media: [email protected]
Investors: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4767ae38-79a4-4de2-bd5f-b2c3c75a4b2b

Tilray (TLRY 2.73%) started its life in the marijuana sector. A few years ago, marijuana was a hot investment theme, and the stock soared on lofty investor expectations for the increasingly legal drug. Realty didn't match expectations, however, and marijuana stocks like Tilray have tanked (it is down more than 95% from its all-time highs).

The company has shifted gears. The recent move to buy Brewdog is an example of the direction change, but it doesn't look like a great decision right now. Here's what you need to know.

Image source: Getty Images.

Tilray bought a troubled asset Tilray isn't exiting the marijuana space; it is expanding into other areas, most notably craft brewing. The goal is to shift from being a pot stock to being a brand manager, describing itself as "a global lifestyle and consumer packaged goods company." The packaged goods just happen to be marijuana, CBD, and alcohol.

So the decision to buy Brewdog, a well-known craft brewer, makes logical sense. And the price was fairly modest, with the U.K. side of the business costing around $44 million. The company didn't announce a cost for the U.S. side, but it is unlikely that Tilray, which is itself a fairly small company, paid a huge sum.

That said, Brewdog's U.K. business hasn't been doing very well. Since Brewdog started the sales process, its own sales have fallen 22.5% with volumes down nearly 22%, according to The Grocer. The declines have been accelerating, according to that industry watcher. That's bad news for Tilray and suggests that it stepped into a bit of a mess.

Today's Change

(

-2.73

%) $

-0.14

Current Price

$

4.98

Tilray knew it was buying a fixer-upper That said, Tilray didn't actually buy all of Brewdog. It was selective about which company locations it acquired (the rest were shut down), and it was likely most interested in the company's craft brew brands, anyway. And while Brewdog's share of the craft brew market in the U.K. has fallen, it is still nearly 50%. That's not a bad bolt-on for Tilray as it looks to reposition its business.

There will likely be a transition period as Tilray integrates Brewdog into its broader business. It wouldn't be shocking to see weak sales trends during this period, since Tilray will have to figure out exactly what it wants to do with the brands it has acquired and then implement those plans. So the Brewdog acquisition could look like, well, a dog for a while. The real test will be where Brewdog's brands are a year or two from now.

Tilray is a high-risk investment Tilray is a money-losing business in the middle of a major overhaul because its early focus on marijuana didn't work out as well as hoped. Buying Brewdog was a part of that business overhaul. All but the most aggressive investors should probably avoid Tilray.

That said, it is probably too early to assess the company's Brewdog purchase. Sure, it looks like a potential mess right now, but management likely knew it would need to turn the business around when it acquired it. It's reasonable to afford Tilray some time to put its imprint on the craft brewer's brands.

Tilray Brands, Inc. (TLRY - Free Report) closed the most recent trading day at $5.03, moving +1.82% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.3%. Meanwhile, the Dow experienced a drop of 0.16%, and the technology-dominated Nasdaq saw an increase of 0.86%.

The company's stock has dropped by 11.15% in the past month, falling short of the Medical sector's gain of 3.12% and the S&P 500's gain of 1.92%.

The investment community will be paying close attention to the earnings performance of Tilray Brands, Inc. in its upcoming release. The company is forecasted to report an EPS of -$0.01, showcasing a 105% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $268.17 million, indicating a 19.43% upward movement from the same quarter last year.

For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.58 per share and a revenue of $885.3 million, representing changes of -680% and +7.79%, respectively, from the prior year.

Investors should also pay attention to any latest changes in analyst estimates for Tilray Brands, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Tilray Brands, Inc. currently has a Zacks Rank of #3 (Hold).

The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 147, this industry ranks in the bottom 40% of all industries, numbering over 250.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

ELLON, Scotland, June 10, 2026 (GLOBE NEWSWIRE) -- Scottish Brewer, BrewDog, by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), is celebrating the highly anticipated U.K. launch of 24 Tilray-owned American craft beers, bringing some of the most iconic and recognizable U.S. craft brands across the United Kingdom beginning this week. Launching exclusively through BrewDog initially, the collaboration marks the first step in a broader strategy to expand Tilray’s American craft beer portfolio across additional retail, grocery, and on-trade channels throughout the U.K. and Europe over time.

As a long-time champion of great craft beer, BrewDog will serve as the gateway for U.K. consumers to discover these authentic American craft beer styles, fresh from the U.S., primarily available on draught in all BrewDog bars and direct to consumers through Brewdog.com. This introduction signifies the expansion of BrewDog’s offering beyond its own-brewed portfolio, with the ambition to roll out the craft brands further into U.K. grocery and on-trade, eventually brewing at BrewDog’s home of craft beer, in Ellon.

Rajnish Ohri, President, International, Tilray Brands, stated: “Launching Tilray’s American craft beer brands across BrewDog’s U.K. platform is a major milestone in our global beverage strategy. We are bringing some of the most widely known American craft beers in the U.S. to new consumers internationally through a powerful retail and distribution platform. This is just the beginning. We see significant long-term opportunity to continue expanding our craft beverage portfolio globally across beer, spirits, non-alcoholic beverages, and ready-to-drink categories as we build a scaled international beverage business.”

Lauren Carrol, Chief Commercial Officer, BrewDog adds, “BrewDog has always championed great craft beer and bold innovation. Bringing these authentic American craft brands to the U.K. expands choice for consumers, introduces exciting new beer styles, and reinforces BrewDog’s role at the centre of craft beer culture. With an established distribution network and strong consumer reach, BrewDog is well positioned to scale premium American craft beer brands across the U.K. We’ve carefully curated this portfolio to deliver the brands, styles, and flavour profiles we believe will resonate most with U.K. drinkers — from engaged craft beer fans to consumers discovering the category for the first time. This is what we do best – delivering quality liquid to people that love beer, and with the support of Tilray we’re excited to establish a place for great-tasting authentic American craft beer in the U.K. market.”

Arriving directly from U.S. breweries on Thursday 11th June, in time for an epic summer of sport, the launch of these fresh, authentic, brews, curated by BrewDog, marks the first time many of them will be available to the U.K. market1. The line-up includes:

Sweetwater Brewing Company – a collection of six fruity IPAs and American-style lagers, brewed in Atlanta

420 Extra Pale Ale (5.7% ABV)Atlanta’s OG IPA (6.3% ABV)G13 Hazy IPA (6% ABV)American Lager (4.5% ABV)Ice Cold Phatty – High Gravity Lager (7% ABV)Goin Coastal – Pineapple IPA (6.1% ABV) 10 Barrel Brewing Co. – four American IPAs, a Double IPA and Japanese-Style Lager from Oregon

Always Down Double IPA (9% ABV)Apocalypse West Coast IPA (6.8% ABV)Cloud Mentality Hazy IPA (7% ABV)Money Cat Japanese-Style Lager (4.8% ABV)Camp Colide Northwest IPA (5% ABV)Juicy Drama Imperial IPA (9% ABV) Montauk Brewing Co. – two high-quality approachable craft ales, from a premium lifestyle craft beer brand, established in Montauk, New York

Wave Chaser IPA (6.4% ABV)Summer Ale (5.5% ABV) Shock Top – a refreshing Belgian-style wheat beer offering an escape from the mundane

Belgian White Wheat Beer (5.2% ABV) Terrapin Beer Co. – two high-octave Double IPAs and a Czech-style Pils from Georgia

Imperial Hopsecutioner Killer Double IPA (9.8% ABV)Imperial Luau Krunkles – Passion Fruit – Orange – Guava Double IPA (9% ABV)Sound Czech – Czech-style Pilsner (5.2% ABV) Blue Point Brewing Co. – welcomes its flagship Toasted Lager and Summer Ale, also from New York

Summer Ale (4.5% ABV)Toasted Lager (5.5% ABV) Green Flash Brewing Co. – the pioneering benchmark for West Coast IPA

West Coast IPA (7% ABV) Alpine Beer Company – this small-town Californian brewery introduces two 7% ABV IPAs

Nelson IPA (7% ABV)Duet IPA (7% ABV) Runner’s High Brewing Company – Golden Wheat – a naturally crafted non-alcoholic brew

Golden Wheat (<0.5% ABV) Initial research shows the appeal for authentic craft beer fresh from the U.S. is there. A BrewDog study identified over 50% of beer drinkers find the new brands either very appealing or somewhat appealing, particularly for drinkers aged 18-342, with the new styles delivering even higher levels of appeal with existing craft beer drinkers3.

To celebrate the launch, BrewDog bars across the U.K. will serve curated U.S. Beer Flights featuring four 1/3 pint pours for £12.95, giving drinkers the chance to explore some of America’s well-known craft beer styles in one experience. Supported by high-energy in-bar activations tied to the summer’s biggest sporting moments, including the World Cup and Independence Day celebrations, BrewDog is set to become the destination for fans looking to discover authentic American craft beer culture this summer.

About BrewDog  
BrewDog has always had one mission: making people as passionate about great beer as we are.  
From iconic classics like Punk IPA, to crowd-pleasers like Lost Lager and Wingman, to boundary-pushing innovations like NanoDog, BrewDog has been brewing bold, distinctive beers since 2007.
Born in Scotland and built by a passionate community of beer lovers, BrewDog has grown into one of the world’s most recognizable craft beer brands, with a global presence spanning breweries, bars and distribution across multiple international markets. BrewDog’s future will continue to be shaped by the three things that matter most: People, Planet and Beer.

For more information, visit www.brewdog.com or follow @BrewDog on social media.  

About Tilray Brands 
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

For more information on how we are elevating lives through moments of connection, visit

Tilray.com and follow @Tilray on all social platforms. 

Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.  

Tilray Brands Contacts:
Media 
[email protected]

Investor Relations 
[email protected]

1 Green Flash and Shock Top have previously had minimal distribution through U.K. wholesalers
2 VYPR BESPOKE POLL – BEER DRINKERS ONLY (722) - ‘Do you find this beer brand appealing’, visual above provided
3 VYPR BESPOKE POLL – BEER DRINKERS ONLY (722) - ‘Do you find this beer brand appealing’, visual above provided - 71% for Sweetwater and Montauk, 79% for Shocktop, 83% for Terrapin and 85% for Bluepoint

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5507d563-c9de-4f28-9683-17f0a8359eb9

Tilray operates primarily as a cannabis wholesaler in Canada and Europe. Trulieve, one of the largest multistate cannabis operators in the U.S., is about to start trading on the New York Stock Exchange.

At GTC Taipei, NVIDIA introduced the RTX Spark Superchip, a platform capable of delivering up to 1 petaflop of AI performance while bringing the company’s CUDA and RTX ecosystem to Windows PCs.

Arm Momentum Continues“NVIDIA’s entry into the AI PC market has the potential to reshape what has become a relatively mature PC industry by creating a new category of local AI inference machines,” the analysts wrote.

Why NVIDIA May Be DifferentCounterpoint argued that RTX Spark could stand apart from existing Arm-based PCs because it combines a high-performance GPU, unified memory architecture, and direct compatibility with NVIDIA’s widely used AI software stack.

The firm said the platform could become one of the most compelling systems for running large language models, AI agents, and generative AI applications directly on a PC.

NVIDIA’s extensive CUDA developer ecosystem and links to its broader AI infrastructure portfolio could also help reduce software bottlenecks and speed adoption.

Key Challenges RemainDespite the opportunity, Counterpoint said NVIDIA still must prove that Windows on Arm software compatibility is mature enough for broad adoption.

Pricing could also be a hurdle. The firm noted that high-performance AI hardware typically comes with higher costs, making market positioning critical.

Counterpoint added that widespread adoption will ultimately depend on whether local AI inference becomes a mainstream consumer use case rather than remaining limited to developers and AI professionals.

The report was authored by Counterpoint Research analysts Minsoo Kang and David Naranjo and published on Friday.

NVDA Price Action: NVIDIA shares were up 0.61% at $206.11 during premarket trading on Friday, according to Benzinga Pro data.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Nvidia Corporation remains a compelling buy as new growth catalysts and robust Q1 results reinforce the bullish thesis despite recent share price weakness. NVDA's Q1 revenue surged 85% Y/Y to $81.62B, with strong guidance, an $80B buyback, and a dividend hike signaling enduring growth momentum. Expansion into AI CPUs, PC superchips, and deepening partnerships with Apple, Microsoft, and SK hynix open significant new addressable markets for NVDA.

It hasn’t been all too clean a breakout for shares of AI chip giant Nvidia (NASDAQ:NVDA | NVDA Price Prediction), which is still down close to 13% after tumbling off its mid-May highs. Indeed, it seems like the company can do everything right and still get rewarded with a reaction that’s relatively muted compared to the rest of the semiconductor scene.

Even if some think that shares of Nvidia have run into a bit of a ceiling just shy of the $6 trillion market cap mark, I still think there are a lot of reasons it might make sense to give the GPU titan the benefit of the doubt.

Of course, the bears, including the likes of Michael Burry of The Big Short fame, also have compelling bear points. But, at the end of the day, it’s up to investors to consider the points from both camps before making a decision on a stock that may very well be among the most puzzling of the Magnificent Seven for more reasons than one.

In this piece, we’ll run through three reasons why Nvidia stock might still be worth keeping on the radar, even if it seems like any further appreciation will be more of a slog.

The stock is starting to look ridiculously cheap One of the top reasons for interested buyers has to be the valuation. The company is backing up its appreciation with earnings growth. And until that changes or the stock starts getting going again, shares are bound to stay cheap-looking. But just because the price-to-earnings (P/E) multiple is low at 31.3 times or just 22.8 times forward P/E does not mean shares are actually an undervalued bargain hiding in plain sight at the very top of the market.

Of course, it depends on whether demand for AI and the hardware that goes along with it will still stay strong. At this juncture, it’s looking like AI demand is only getting stronger. And as Nvidia readies for the Vera Rubin age while getting into the PC superchip market with RTX Spark, an argument could be made that the off-the-charts growth numbers aren’t about to reverse course, but continue higher.

Based on the market cap, Nvidia looks like another semiconductor stock in a bubble. But based on the financials, it’s a hyper-growth firm in a class of its own.

Competition exists, but Nvidia has stayed a step above It’s all about custom silicon these days. New ASIC innovations hold plenty of promise as the inference wave rolls in. But, at the same time, Vera Rubin is on the horizon, and it’s going to sell. Given the massive leaps Nvidia has made over the past generation, and where AI demand could go from here if some of the AI bulls are proven right, perhaps that big reversal might not be right around the corner.

Smart bets and collabs across the AI stack Nvidia’s rolling in big money, and it’s investing in across layers of the stack that go above and beyond the hardware layer.

Whether we’re talking about betting on connectivity or the formation of alliances with some of the other forces (think the top AI labs), helping to fuel the AI boom, every collaboration that the firm makes may very well give Nvidia exposure to the AI revolution. Whether we’re talking about the stakes in the interconnect plays

Nvidia Corporation is rated Overweight with a $305 price target, offering 50%+ upside, as the current 15x forward P/E deeply discounts growth durability. Networking revenue is compounding faster than compute, with NVDA's full-stack system and CUDA platform reinforcing a wide, stable moat against custom ASIC threats. Guidance excludes China Data Center compute, making any China reopening pure upside optionality not reflected in current estimates or valuation.

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and AMD (NASDAQ:AMD) both reported earnings in May, and the contrast says everything about today’s AI hardware market.

NVIDIA posted a $81.6 billion quarter built on Blackwell dominance. AMD posted $10.25 billion, with the Meta partnership reshaping its data center story. One is the incumbent. The other is the credible challenger finally getting customer commitments at scale.

Blackwell Carries NVIDIA. Meta and MI450 Carry AMD. NVIDIA’s Data Center segment hit $75.25 billion, up 92% year over year, with networking alone at $14.8 billion (+199%). That networking line is bigger than AMD’s entire data center business. Jensen Huang framed it bluntly: “The buildout of AI factories, the largest infrastructure expansion in human history, is accelerating at extraordinary speed.”

AMD’s quarter was smaller but accelerating. Data Center revenue reached $5.78 billion (+57%), and Lisa Su told investors “Customer engagement around MI450 Series and Helios is strengthening, with leading customer forecasts exceeding our initial expectations.”

The 6 GW Meta deployment, starting with a custom MI450 design, gives AMD something it has lacked: a flagship hyperscaler willing to bet on its accelerator roadmap.

One Sells the Whole Factory. The Other Sells the Best Alternative. NVIDIA’s platform sweep keeps widening. Vera Rubin pairs a custom CPU with Rubin GPUs, Dynamo 1.0 reportedly lifts Blackwell inference up to 7x, and partnerships with Marvell, Corning, Lumentum, and Coherent lock in the optics layer.

AMD’s counter is ROCm maturity, HBM4 collaboration with Samsung for the MI455X, and 6th Gen EPYC (Venice/Verano) with Meta as lead customer. Different shapes of moat.

Lens NVIDIA AMD Q1 Revenue Growth +85.2% YoY +37.9% YoY Non-GAAP Gross Margin 75.0% 55% Next-Q Guide $91.0B ~$11.2B Forward P/E 24 68 The valuation gap matters. AMD trades at a trailing P/E of 159 after a 128% YTD run. NVIDIA, despite reporting a $58 billion net income quarter, carries a forward multiple of 24. Cheaper than its smaller rival.

What Decides the Second Half I will watch three things. First, whether MI450 customer forecasts translate into firm orders that show up in AMD’s Q3 earnings report.

Second, NVIDIA’s China exposure, since Q2 guidance excludes any Data Center compute revenue from China, leaving upside if policy shifts.

Third, supply. NVIDIA already locked in $119 billion of supply commitments, while AMD is still negotiating HBM4 capacity with Samsung.

Why I Lean NVIDIA Heading Into Summer On a risk-adjusted basis, NVIDIA screens more favorably on the current data. The valuation spread is notable: AMD trades at 68x forward earnings while growing 38%, versus NVIDIA at 24x growing 85% with 75% gross margins, alongside a $80 billion fresh buyback and a 25x dividend hike.

NVIDIA shares have also cooled, down 8.2% since the May 20 report, while AMD rose 37.5%. The AMD case rests on Helios reshaping the competitive map; the NVIDIA case rests on scale, cash generation, and a cleaner near-term setup.

Nvidia stock edged lower on Friday even as the chipmaker continued to expand its global artificial intelligence footprint through new partnerships, product initiatives, and growing demand for its next-generation processors.

Shares of Nvidia NVDA slipped 0.18% during trading.

The modest decline came despite a series of developments that highlighted the company's efforts to strengthen its position in AI infrastructure markets both inside and outside the United States.

The company has reportedly begun informing Chinese customers that they can place orders for its new Vera central processing units, with shipments potentially beginning in August.

The move could provide Nvidia with another avenue into the Chinese market, where export restrictions have limited sales of some of its advanced AI products.

According to Reuters, one major Chinese cloud provider is preparing an initial order for more than 300 servers built around Nvidia Vera chips.

Customers are expected to first test the systems in overseas data centers before deciding whether to proceed with larger deployments.

Nvidia reportedly sees Vera as a potential $20 billion revenue opportunity by the end of its fiscal year in January.

Unlike the company's graphics processing units, which remain subject to tighter US export restrictions, the processor business may face fewer regulatory hurdles.

Beyond China, Nvidia continues to broaden its reach through major AI infrastructure agreements.

Australian cloud-infrastructure provider SharonAI Holdings announced a six-year partnership with Nvidia to build 72 megawatts of new data-center capacity across Australia.

The project will deploy up to 40,000 Nvidia AI processors to support startups, enterprises, and university researchers.

Under the agreement, Nvidia will receive revenue from processor sales as well as a share of cloud revenue generated through SharonAI's hosting services.

Additional signs of demand have emerged globally. Nebius Group plans to invest approximately $2.275 billion in next-generation facilities in the United Kingdom powered by Nvidia's Vera Rubin products.

Meanwhile, Nvidia's partnership with SK Telecom aims to build AI-capable cloud infrastructure in South Korea focused on both AI training and inference workloads.

“Inference is crucial to the outlook, as it is the application of AI and a much larger market segment than infrastructure and training,” Nvidia CEO Jensen Huang has previously emphasized, highlighting the growing importance of AI deployment beyond model development.

Analysts remain bullish on AI demandAnalysts continue to express confidence in Nvidia's outlook following recent industry events, including the Taiwan Computex conference.

Analysts at Wedbush and UBS believe demand for GPUs remains strong while supply capacity continues to lag, creating favorable conditions for Nvidia in the coming quarters.

Wedbush also suggested that the AI hardware upgrade cycle may be accelerating as demand for Nvidia's Blackwell platform remains stronger than expected later in its product cycle.

The company is currently covered by 54 analysts, with approximately 95% maintaining Buy recommendations.

Nvidia has also continued investing in technologies designed to strengthen its long-term AI ecosystem.

One of its latest acquisitions is Kumo AI, an enterprise-focused predictive agent platform that helps forecast operational needs using customer data.

The technology is expected to complement Nvidia's broader physical AI strategy, including warehouse automation applications.

At the same time, Nvidia continues to invest heavily in future production capacity and supply-chain resilience.

While industry-wide constraints remain, analysts view Nvidia as one of the best-positioned companies to navigate potential shortages and meet rising AI demand.

SpaceX (SPCX) closed out the week with a $2 trillion IPO at the Nasdaq, but it wasn't the only stock that moved markets today. Marley Kayden and Sam Vadas talk about the historic public trading debut, along with Mag 7 headlines in Nvidia (NVDA) and Meta Platforms (META).

American Airlines is rated Buy despite a challenged balance sheet and volatile fuel costs, as the market is undervaluing structural revenue recovery. Premium cabin load factors and AAdvantage loyalty enrollment are at record highs, with corporate and SME travel revenue up 13% and 28%, respectively. Management reduced debt by $1.8 billion in Q1, prioritizing free cash flow and balance sheet improvement over aggressive fleet expansion.

American Airlines is temporarily suspending six domestic routes this summer as elevated fuel costs linked to the Iran conflict continue to pressure carriers across the airline industry. 

The major air carrier said the affected routes will be paused only during August and September and emphasized that no routes are being eliminated permanently, according to FOX 5 New York. 

A separate report from Simple Flying said the routes will be out of service from Aug. 5 through Oct. 5. 

"American has seasonally adjusted service on select routes in August and September as the airline refines its capacity growth for 2026," American said. 

AMERICAN AIRLINES JOINS WAVE OF CARRIERS HIKING CHECKED BAG FEES AS JET FUEL PRICES SKYROCKET

An American Airlines airplane approaches Miami International Airport for landing in Miami, Florida.  (Ronen Tivony/NurPhoto via Getty Images / Getty Images)

According to Simple Flying, the affected routes include: 

Los Angeles (LAX) to Cleveland (CLE)Los Angeles (LAX) to Columbus (CMH)Los Angeles (LAX) to Pittsburgh (PIT)Los Angeles (LAX) to Washington Dulles (IAD)Charlotte (CLT) to Ontario (ONT)Charlotte (CLT) to Sacramento (SMF)Simple Flying noted that the Los Angeles-to-Cleveland route was one of the newest additions to American's network, having launched in April. The suspension announcement comes just after two months of service.  

Passengers affected by the schedule changes will be offered alternative travel arrangements or refunds, FOX 5 reported.  

"Travelers on impacted routes will be offered alternate travel arrangements or a refund in line with American’s customer-friendly schedule change policy," the airline said.

UNITED AIRLINES RAISING TICKET PRICES UP TO 20% AS FUEL COSTS SURGE AMID IRAN WAR

Cars move through the horseshoe for arrival pickups and departure drop-offs near Terminal 2 at Los Angeles International Airport (LAX) on March 24, 2026, in Los Angeles, California. (Luke Hales/Getty Images / Getty Images)

American previously announced in April that it would raise checked baggage fees by at least $10 as the airline grapples with rising jet fuel costs, mirroring similar moves by other carriers, including United, Delta, Southwest and JetBlue. 

Since fighting in the Middle East intensified earlier this year, airlines across the industry have implemented a range of cost-cutting measures amid volatile fuel prices, including reducing flight schedules and raising fares to offset higher operating expenses.

UNITED AIRLINES SLASHES FLIGHTS AS IRAN WAR SENDS FUEL PRICES SOARING

American Airlines aircraft seen at Phoenix Sky Harbor International Airport on Feb. 22, 2020. (Alex Tai/SOPA Images/LightRocket via Getty Images / Getty Images)

Last month, United Airlines released a staff memo announcing plans to cut about 5% of capacity by trimming less profitable routes, citing an expected prolonged period of elevated fuel prices.

In April, United also said it had been incrementally raising fares — up to 20% since last year — in an effort to "recover 100% of the increase in jet fuel prices as quickly as possible."

Ticker Security Last Change Change % AAL AMERICAN AIRLINES GROUP INC. 14.96 +0.32 +2.15% GET FOX BUSINESS ON THE GO BY CLICKING HERE

American's decision to suspend select routes also follows the collapse of budget carrier Spirit Airlines, whose financial troubles were compounded by years of mounting losses and higher fuel costs.   

Fox News Digital reached out to American Airlines for more information. 

Fox News Digital's Eric Revell and Michael Dorgan contributed to this report. 

This is the largest of its kind deal between an airline and a single corporate buyer.

• American Airlines Group shares are advancing steadily. Why is AAL stock advancing?

DetailsThe deal will enable the delivery of 35 million gallons (132 million liters) of SAF over three years. The company expects it to reduce nearly 300,000 metric tons of CO₂ equivalent emissions.

The agreement also supports a long-term SAF supply arrangement with Valero Marketing and Supply Company, reinforcing American Airlines' broader commitment to scaling sustainable aviation fuel.

Apart from this, American Airlines collaborated with Google, Flightkeys and Contrails.org on a 16-week 2025 pilot program that embedded contrail avoidance into flight planning.

The trial delivered a statistically significant 62% reduction in contrail formation, along with a meaningful decrease in associated warming impacts.

Earnings & Analyst OutlookLooking further out, the next major catalyst for the stock arrives with the July 23 (estimated) earnings report.

EPS Estimate: 2 cents (Down from 95 cents year-over-year) Revenue Estimate: $16.65 billion (Up from $14.40 billion YoY) Valuation: P/E of 43.9x (Indicates premium valuation relative to peers) Analyst Consensus & Recent Actions: The stock carries a Buy rating with a consensus price target of $16.08 (high: $31; low: $7) across 27 analysts. Recent analyst moves include:

Morgan Stanley: Overweight (Raises target to $24 on June 1) Deutsche Bank: Buy (Raises target to $18 on May 29) UBS: Buy (Raises target to $18 on May 26) Benzinga Edge RankingsBelow is the Benzinga Edge scorecard for American Airlines, highlighting its strengths and weaknesses compared to the broader market:

The Verdict: American Airlines’ Benzinga Edge signal reveals a growth-leaning profile with neutral momentum and only moderate value support. For longer-term bulls, the chart looks healthiest as long as price holds above the $12.50 support zone while it works toward $16 resistance.

Top ETF Exposure Invesco S&P MidCap 400 Revenue ETF (NYSE:RWK): 2.22% Weight US Global Jets ETF (NYSE:JETS): 10.57% Weight Significance: Because American Airlines carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely trigger automatic buying or selling of the stock.

AAL Stock Price Activity: American Airlines Group shares were up 3.79% at $14.12 at the time of publication on Tuesday, according to Benzinga Pro data.

Photo via Shutterstock 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

American Airlines Group Inc. (AAL) Shareholder/Analyst Call Transcript

American Airlines (AAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AT&T (T - Free Report) Based in Dallas, TX, AT&T Inc. is the second largest wireless service provider in North America and one of the world’s leading communications service carriers. Through its subsidiaries and affiliates, the company offers a wide range of communication and business solutions that include wireless, local exchange, long-distance, data/broadband and Internet, video, managed networking, wholesale and cloud-based services.

T is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 10.22; value investors should take notice.

Seven analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.01 to $2.30 per share. T also boasts an average earnings surprise of +5.2%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, T should be on investors' short list.